Advertisement

Related Videos

Varsha Gandhi, PhD, on Ibrutinib

Focus on Optimized Dosing of Ibrutinib Panel Discussion

Daniel Goldstein, MD: Interventional Pharmacoeconomics - Why and How

Ian Tannock, MD, PhD, DSc, on Near-Equivalence: A Better Question Than Non-Inferiority

Charles Schiffer, MD, on Cost-Effective Use of Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia

Advertisement

Advertisement




Apr
29
Today In Oncology
Study Finds Prostate Cancer Overdiagnosis Rises ‘Substantially’ With Age
Tracking Biological Age Changes Gives Insights Into Cancer Prognosis
Neoadjuvant Durvalumab and Chemotherapy in Triple-Negative Breast Cancer: Long-Term Follow-Up of GeparNuevo Trial
Global Review Shows Impact of Exposure to Air Pollution on Cancer Risk and Mortality
Do Political Beliefs Shape Views on Clinical Trials in Cancer?
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo